BillionToOne Inc
NASDAQ:BLLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Powszechny Zaklad Ubezpieczen SA
WSE:PZU
|
PL |
|
Shenzhen Expressway Corp Ltd
SSE:600548
|
CN |
|
Thirdwave Financial Intermediaries Ltd
BSE:531652
|
IN |
|
I
|
Innovaro Inc
OTC:INNI
|
US |
|
Getinge AB
F:GTN0
|
SE |
BillionToOne Inc
Research & Development
BillionToOne Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BillionToOne Inc
NASDAQ:BLLN
|
Research & Development
-49.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Research & Development
-$364.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
BillionToOne Inc
Glance View
BillionToOne Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Menlo Park, California. The company went IPO on 2025-11-06. BillionToOne Inc is a United States-based precision diagnostics company. The firm provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.
See Also
What is BillionToOne Inc's Research & Development?
Research & Development
-49.4m
Based on the financial report for Dec 31, 2025, BillionToOne Inc's Research & Development amounts to -49.4m .
What is BillionToOne Inc's Research & Development growth rate?
Research & Development CAGR 1Y
-35%
Over the last year, the Research & Development growth was -35%.
